Bolt Biotherapeutics (NASDAQ:BOLT) Price Target Cut to $1.00 by Analysts at Stifel Nicolaus
Bolt Biotherapeutics (NASDAQ:BOLT – Get Free Report) had its price objective lowered by equities researchers at Stifel Nicolaus from $1.25 to $1.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage presently has a “hold” rating on the stock. Stifel Nicolaus’ price target points to a potential upside of 185.71% […]
Bolt Biotherapeutics (NASDAQ:BOLT – Get Free Report) had its price objective lowered by equities researchers at Stifel Nicolaus from $1.25 to $1.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage presently has a “hold” rating on the stock. Stifel Nicolaus’ price target points to a potential upside of 185.71% […]
